At present, electrocardiogram production and operation enterprises are "many, small, and low", and the industry R&D investment is significantly lower than that of multinational medical device companies. The organizational production and timely supply of medical equipment and therapeutic drugs such as electrocardiograms are enhanced, the production flexibility of enterprises is scientifically planned, the production capacity is ensured, and the material guarantee coordination mechanism is strengthened.
Electrocardiogram industry development space Analysis of market demand for electrocardiogram industry
Most of the high-end medical device market is occupied by multinational companies, and the situation has not improved significantly, and the problem of relatively insufficient regulatory power of medical device still exists.
Medical devices are in a stage of continuous rapid growth. From the perspective of domestic development environment, China is the largest country with a large population and a large amount of capacity to accommodate the survival of many medical device factories. With the aging population and the improvement of health care awareness, there is broad space for market development.
data shows that China's medical device market only accounts for 14% of the total pharmaceutical market share, which is 42% worldwide; the global electrocardiogram industry is expected to grow by 4.1% annually, and China's compound growth rate in the past six years is about 20%. In addition, domestic electrocardiograms continue to release policy dividends such as building local medical device giants and replacing domestic equipment imports, which undoubtedly injects a booster to the accelerated growth of electrocardiogram companies.
In my country's monitor market, the company with the largest market share is Mindray Medical , accounting for about 40%. The second and third companies are Philips and General Motors, accounting for 24% and 9% of the market share respectively. There are about 70 domestic companies that produce and sell monitoring equipment, including about 10 companies with independent R&D capabilities. Baolai Company has three major monitoring series products: handheld monitor, integrated monitor and plug-in monitor . It is one of the companies with a relatively complete monitoring product line in my country.
According to statistics from China's medical device industry, the total market value of the global vital sign monitor in 2018 reached 24.32 billion yuan, and is expected to grow to 31.62 billion yuan in 2025, with an annual compound growth rate (CAGR) of 3.8%.
From the perspective of demand, the United States, Germany and Japan and other countries continue to grow due to their developed economies and sound social health care systems. China and India have huge growth potential and space, mainly because the two countries have large populations and the health care system is still developing. Especially in China, with the implementation of the new medical reform , many medical and health institutions have gradually upgraded medical devices; in addition, the number of medical institutions in China has increased significantly, which has led to a sharp increase in demand for medical devices and hospital infrastructure. It is expected that the demand for patient monitor will maintain a certain speed in the future.
As the incidence of cardiovascular disease continues to rise, ECG machine is also developing towards multi-channel, new recording methods, digital intelligence, network sharing , etc. China's new ECG machine will also use digital technology to continuously improve work efficiency and accelerate the timeliness of tracing, which will significantly improve the accuracy of clinical diagnosis. The electrocardiogram market will gradually expand, and at the same time, the medical device industry will focus on development in the "14th Five-Year Plan" period, providing a good policy environment for improving the product quality of electrocardiogram.
What is the market prospect of China's electrocardiogram industry? The "In-depth Research on China's Electrocardiograph Industry and Forecasting of Future Development Status and Trends" released by Zhiyanzhan Industry Research Institute in detail analyzes the potential of China's electrocardiograph energy resources, China's electrocardiograph industry policies, China's electrocardiograph energy development and utilization technology, China's electrocardiograph energy utilization industry development, China's electrocardiograph energy utilization industry operation, China's electrocardiograph energy industry development prospects and investment planning, etc., to help enterprises and investors understand the market investment value of China's electrocardiograph energy industry. If you want to have a systematic understanding of the Chinese electrocardiogram energy industry or want to invest in the Chinese electrocardiogram energy industry, this report is an indispensable and important tool for you.
